raj04h/Project_Drug_Finder

This is a 0-star, 0-fork student or academic project (~1 year old) with no observed adoption. The technical approach combines standard, well-established components: ResNet and Random Forest are commodity ML architectures; RDKit and PaDEL are standard cheminformatics libraries used in thousands of drug discovery projects. The task (EGFR bioactivity prediction from molecular descriptors) is a textbook application of ML to chemistry—no novel methodology is evident from the description. Implementation appears to be a reference/prototype rather than production-grade. Frontier labs (Isomorphic Labs, DeepMind, OpenAI) are actively investing in computational drug discovery with substantially more sophisticated approaches (diffusion models, graph neural networks, large foundation models for molecules like ChemBERTa). This project directly competes with: (1) open-source benchmarks like Therapeutics Data Commons, (2) established platforms like ChemAxon or Schrödinger, and (3) emerging LLM-based drug discovery agents that frontier labs are actively deploying. A frontier lab could trivially replicate this as a baseline or feature within a larger platform. No data gravity, switching costs, or community lock-in observed. High frontier risk: exact problem space being pursued by leading AI labs with more resources and better techniques.